• 1
    Australian Health Information Council. AHIC electronic decision support systems report. In: Australian Health Information Council 2008.
  • 2
    Bates DW, Kuperman GJ, Wang S, Gandhi T, Kittler A, Volk L, Spurr C, Khorasani R, Tanasijevic M, Middleton B. Ten commandments for effective clinical decision support: making the practice of evidence-based medicine a reality. J Am Med Inform Assoc 2003; 10: 52330.
  • 3
    Calabretto J, Warren J, Bird L. Pharmacy decision support: where is it? A systematic literature review. Int J Pharm Pract 2005; 13: 15763.
  • 4
    Reeve JF, Tenni PC, Peterson GM. An electronic prompt in dispensing software to promote clinical interventions by community pharmacists: a randomized controlled trial. Br J Clin Pharmacol 2007; 65: 37785.
  • 5
    Hughes JD, Tanpurekul W, Keen NC, Ee HC. Reducing the cost of proton pump inhibitors by adopting best practice. Qual Prim Care 2009; 17: 1521.
  • 6
    Mabasa VH, Ma J. Effect of a therapeutic maximum allowable cost (MAC) program on the cost and utilization of proton pump inhibitors in an employer-sponsored drug plan in Canada. J Manag Care Pharm 2006; 12: 37176.
  • 7
    Mat Saad AZ, Collins N, Lobo MM, O'Connor HJ. Proton pump inhibitors: a survey of prescribing in an Irish general hospital. Int J Clin Pract 2005; 59: 314.
  • 8
    McMullin ST, Lonergan TP, Rynearson CS. Twelve-month drug cost savings related to use of an electronic prescribing system with integrated decision support in primary care. J Manag Care Pharm 2005; 11: 32232.
  • 9
    Batuwitage BT, Kingham JGC, Morgan NE, Bartlett RL. Inappropriate prescribing of proton pump inhibitors in primary care. Postgrad Med J 2007; 83: 668.
  • 10
    Hebbard GS. Proton pump inhibitors: step-down to symptom control. In: Prescribing Practice Review for Primary Care: National Prescribing Service, 2009: 4.
  • 11
    Department of Veterans Affairs. PPIs in GORD: reduce the dose – keep the benefits. Therapeutic Brief 7. In: Department of Veterans Affairs. 2010.
  • 12
    Abbott R, Best J, Buckley N, Donovan J, Dowden J, Parker S, Rossi S. NPS News 46: proton pump inhibitors. In: NPS News: National Prescribing Service. 2006.
  • 13
    Peterson G, Tenni P, Jackson S, Bereznicki L, Hughes J, Kong D, Doran C, Williams M, Curtain C, Hughes J, Ellerton L, Bindoff I. Documenting clinical interventions in community pharmacy: PROMISe III. 2010.
  • 14
    Peterson GM, Tenni PT. Identifying, prioritising and documenting drug-related problems. Aust Pharm 2004; 23: 70609.
  • 15
    Department of Health and Ageing. PhARIA pharmacy access/remoteness index of Australia. In: The University of Adelaide.
  • 16
    Gastroenterological Society of Australia. Gastro-oesophageal reflux disease in adults: guidelines for clinicians. In: Gastroenterological Society of Australia. 2008.
  • 17
    Department of Health and Ageing. Schedule of pharmaceutical benefits July 2009. In, Department of Health and Ageing, Canberra: Commonwealth of Australia. 2009.
  • 18
    Pharmacy Guild of Australia. 2008 Guild Digest. Canberra: Pharmacy Guild of Australia, 2008.
  • 19
    Humphries TL, Carroll N, Chester EA, Magid D, Rocho B. Evaluation of an electronic critical drug interaction program coupled with active pharmacist intervention. Ann Pharmacother 2007; 41: 197985.
  • 20
    Moxey A, Robertson J, Newby D, Hains I, Williamson M, Pearson SA. Computerized clinical decision support for prescribing: provision does not guarantee uptake. J Am Med Inform Assoc 2010; 17: 2533.
  • 21
    Isaac TI, Weissman JS, Davis RB, Massagli M, Cyrulik A, Sands DZ, Weingart SN. Overrides of medication alerts in ambulatory care. Arch Intern Med 2009; 169: 30511.
  • 22
    Peterson GM, Tenni PT, Kruup H, Hasan O, Reeve JF. Evaluation of Clinical Interventions within Community Pharmacy (Promise II). Canberra: Pharmacy Guild of Australia, 2003.
  • 23
    Stevenson FA, Greenfield SH, Jones M, Nayak A, Bradley CP. GPs' perceptions of patient influence on prescribing. Fam Pract 1999; 16: 25561.